Jiří Nečas

1.3k total citations · 1 hit paper
38 papers, 1.0k citations indexed

About

Jiří Nečas is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Jiří Nečas has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Complementary and alternative medicine. Recurrent topics in Jiří Nečas's work include Cardiac Ischemia and Reperfusion (5 papers), Medicinal Plants and Neuroprotection (3 papers) and Metabolism and Genetic Disorders (3 papers). Jiří Nečas is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Medicinal Plants and Neuroprotection (3 papers) and Metabolism and Genetic Disorders (3 papers). Jiří Nečas collaborates with scholars based in Czechia and Slovakia. Jiří Nečas's co-authors include Lenka Bartošíková, P. Brauner, J Kolár, Václav Suchý, El Moataz Bellah El Naggar, Milan Žemlička, Martin Modrianský, Emil Švajdlenka, J. Illek and Renata Kubínová and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Fitoterapia.

In The Last Decade

Jiří Nečas

34 papers receiving 960 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyaluronic acid (hyaluronan): a review

2008 762 citations Jiří Nečas, Lenka Bartošíková et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiří Nečas Czechia	10	248	220	201	167	119	38	1.0k
P. Brauner Czechia	5	262 1.1×	291 1.3×	196 1.0×	153 0.9×	138 1.2×	8	1.2k
Annalisa La Gatta Italy	20	285 1.1×	173 0.8×	219 1.1×	163 1.0×	159 1.3×	47	1.2k
Kamil Kamiński Poland	18	109 0.4×	164 0.7×	265 1.3×	164 1.0×	137 1.2×	59	966
Chien-Ho Chen Taiwan	22	90 0.4×	396 1.8×	296 1.5×	201 1.2×	125 1.1×	34	1.5k
Lenka Bartošíková Czechia	10	255 1.0×	320 1.5×	305 1.5×	209 1.3×	122 1.0×	26	1.6k
J. Helen Fitton Australia	27	86 0.3×	422 1.9×	268 1.3×	248 1.5×	177 1.5×	55	2.7k
Jae Wook Yang South Korea	24	73 0.3×	475 2.2×	289 1.4×	191 1.1×	259 2.2×	110	1.9k
Antonietta Stellavato Italy	19	313 1.3×	288 1.3×	119 0.6×	68 0.4×	121 1.0×	47	1.0k
Mara Massimi Italy	21	47 0.2×	426 1.9×	178 0.9×	252 1.5×	147 1.2×	52	1.3k
Zhiwen Jiang China	25	77 0.3×	420 1.9×	593 3.0×	243 1.5×	169 1.4×	89	1.6k

Countries citing papers authored by Jiří Nečas

Since Specialization

Citations

This map shows the geographic impact of Jiří Nečas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Nečas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Nečas more than expected).

Fields of papers citing papers by Jiří Nečas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Nečas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Nečas. The network helps show where Jiří Nečas may publish in the future.

Co-authorship network of co-authors of Jiří Nečas

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Nečas. A scholar is included among the top collaborators of Jiří Nečas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Nečas. Jiří Nečas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kraus, Josef, et al.. (2021). Movement disorders, cerebral palsy and vaccination. European Journal of Paediatric Neurology. 36. 143–150. 3 indexed citations

2.

Bartošíková, Lenka, et al.. (2018). Cardioprotective effect of 2,3-dehydrosilybin preconditioning in isolated rat heart. Fitoterapia. 132. 12–21. 13 indexed citations

3.

Bartošíková, Lenka, et al.. (2015). Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart. PLoS ONE. 10(9). e0139208–e0139208. 9 indexed citations

4.

Bartošíková, Lenka, et al.. (2010). Effect of pomiferin administration on kidney ischaemia-reperfusion injury in rats. Interdisciplinary Toxicology. 3(2). 76–81. 6 indexed citations

5.

Bartošíková, Lenka, et al.. (2008). CHANGES IN BIOMECHANICAL PARAMETERS DURING HEART PERFUSION AND AFTER MIDAZOLAM PRE-MEDICATION - EXPERIMENTAL PILOT STUDY. Biomedical Papers. 152(1). 79–82. 5 indexed citations

6.

Nečas, Jiří, et al.. (2007). Protective Effects of Flavonoid Pomiferin on Heart Ischemia-Reperfusion. Acta Veterinaria Brno. 76(3). 363–370. 2 indexed citations

7.

Bartošíková, Lenka, et al.. (2006). [Morin in the therapy of the ischemia-reperfusion damage model of the rat kidney].. PubMed. 55(2). 78–83. 2 indexed citations

8.

Bébarová, Markéta, et al.. (2006). Ultrashort Bradycardic Effect of Newly Synthesized Compounds. Acta Veterinaria Brno. 75(2). 183–196. 2 indexed citations

9.

Nečas, Jiří, et al.. (2006). EFFECTS OF PRENYLATED ISOFLAVONES OSAJIN AND POMIFERIN IN PREMEDICATION ON HEART ISCHEMIA-REPERFUSION. Biomedical Papers. 150(1). 93–100. 28 indexed citations

10.

Nečas, Jiří, et al.. (2006). [Protective effects of the flavonoids osajin and pomiferin on heart ischemia-reperfusion].. PubMed. 55(4). 168–74. 9 indexed citations

11.

Bartošíková, Lenka, et al.. (2005). Effects of Pomiferin Premedication on the Antioxidant Status of Rats with Ischemia-Reperfused Kidney. Acta Veterinaria Brno. 74(4). 557–564. 6 indexed citations

12.

Naggar, El Moataz Bellah El, et al.. (2005). Antidiabetic Effect of Cleome droserifolia Aerial Parts: Lipid Peroxidation-Induced Oxidative Stress in Diabetic Rats. Acta Veterinaria Brno. 74(3). 347–352. 37 indexed citations

13.

Nečas, Jiří, et al.. (2004). Influence of New Ultrashort-Acting Beta-Adrenergic Blockers on Systolic Blood Pressure in Rats. Acta Veterinaria Brno. 73(2). 181–185. 4 indexed citations

14.

Bartošíková, Lenka, Jiří Nečas, Václav Suchý, et al.. (2003). Antioxidative Effects of Morine in Ischemia-Reperfusion of Kidneys in the Laboratory Rat. Acta Veterinaria Brno. 72(1). 87–94. 9 indexed citations

15.

Bartošíková, Lenka, Jiří Nečas, Václav Suchý, et al.. (2003). Monitoring of Antioxidative Effect of Morine in Alloxan-induced Diabetes mellitus in the Laboratory Rat. Acta Veterinaria Brno. 72(2). 191–200. 16 indexed citations

16.

Nečas, Jiří. (2003). Paper tape. 1348–1349.

17.

Nečas, Jiří, et al.. (2000). Lactate Dehydrogenase Isoenzyme Pattern in Tissues and Serum of the Calf. Acta Veterinaria Brno. 69(4). 267–275. 10 indexed citations

18.

Nečas, Jiří, et al.. (1997). [The effects of Carvedilol, a beta-blocker, in experimental ischemia-reperfusion kidney injury].. PubMed. 43(11). 707–11. 4 indexed citations

19.

Nečas, Jiří, et al.. (1994). Retrospective biochemical and immunological studies in long-term survival of TAH calaves. Pathophysiology. 1(2). 99–104.

20.

Nečas, Jiří, et al.. (1992). Biochemical and immunological studies in calves living over three months with a total artificial heart.. PubMed. 15(2). 120–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact